METACARD MR Trimetazidine Hydrochloride 35mg Modified-Release Tablet 1's
RXDRUG-DRP-6781-1pc
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications/Uses
Metacard MR Tablet is a metabolic treatment for ischemic heart disease. It can be used at all stages of angina pectoris and in post myocardial infarction. Metacard MR therapy has also demonstrated beneficial effects when administered during bypass surgery.
Dosage/Direction for Use
One tablet at mealtimes in the morning and evening.
Contraindications
Trimetazidine is contraindicated in - patients with a known hypersensitivity to its components.
Side Effects
Trimetazidine is safe and well tolerated. Rare cases of gastrointestinal disorders, nausea & vomiting have been reported.
Storage
Store below 30°C and protect from light.
MedsGo Class
Anti-Anginal Drugs
Features
Brand
Metacard Mr
Full Details
Dosage Strength
35 mg
Drug Ingredients
- Trimetazidine
Drug Packaging
Modified-Release Tablet 1's
Generic Name
Trimetazidine Hydrochloride
Dosage Form
Modified-Release Tablet
Registration Number
DRP-6781
Drug Classification
Prescription Drug (RX)
Please sign in so that we can notify you about a reply